European Commission
Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
17:00 Brussels time
Last verified:
Details
| Funder | European Commission |
| Budget | €7M–€8M per grant |
| Deadline | 15 September 2026 |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Application | Single-stage |
| Frequency | One-off |
Eligibility & scope
Horizon Europe RIA (lump sum) for academic investigator-initiated pragmatic clinical trials on immunotherapeutic interventions for refractory cancer patients. Proposals must include a clinical studies annex, disaggregate data by sex/gender/age, and engage patients in endpoint definition. Applicants must include diverse stakeholders and plan to join the EU Cancer Mission 'Diagnosis and Treatment' cluster. ~3 grants expected.
Related on Grantsby
- European Commission writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from European Commission
Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2026
Deadline: 9 Sept 2026Marie Skłodowska-Curie Actions Postdoctoral Fellowships (MSCA-PF) 2026
Deadline: 9 Sept 2026MSCA Postdoctoral Fellowships 2026
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships (HORIZON-TMA-MSCA-PF-EF)
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships (HORIZON-TMA-MSCA-PF-GF)
Deadline: 9 Sept 2026
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free